Schroder Investment Management Group
TMDX icon

Schroder Investment Management Group’s Transmedics TMDX Stock Holding History

Schroder Investment Management Group’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-283,107
Closed -$16.8M – 1263
2024
Q4 		$16.8M Buy
283,107
+153,688
+119% +$14.3M 0.02% 549
2024
Q3 		$20.6M Buy
+129,419
New +$19.9M 0.02% 506

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Schroder Investment Management Group's TMDX Position: Q1 2025 in Review

Schroder Investment Management Group sold out of Transmedics (TMDX) in Q1 2025, closing a stake of 283,107 shares — an estimated $16.8M sold.

Schroder Investment Management Group first reported a position in TMDX in Q3 2024 and held it in 2 quarters. The position peaked at $20.6M in Q3 2024. 298 funds tracked by Wall St. Rank hold TMDX as of Q1 2025.

  • Schroder Investment Management Group reported no remaining Transmedics position as of Q1 2025 after selling out during the quarter.
  • Schroder Investment Management Group sold 283,107 Transmedics shares in Q1 2025, an estimated $16.8M.
  • Schroder Investment Management Group first reported a position in Transmedics in Q3 2024 and held it in 2 quarters.
  • Schroder Investment Management Group's Transmedics position peaked at $20.6M in Q3 2024.
  • 298 funds tracked by Wall St. Rank held Transmedics as of Q1 2025.

Based on Schroder Investment Management Group's 13F filing for Q1 2025, filed 13 May 2025.